Literature DB >> 21490387

The effect of uterine motion and uterine margins on target and normal tissue doses in intensity modulated radiation therapy of cervical cancer.

J J Gordon1, E Weiss, O K Abayomi, J V Siebers, N Dogan.   

Abstract

In intensity modulated radiation therapy (IMRT) of cervical cancer, uterine motion can be larger than cervix motion, requiring a larger clinical target volume to planning target volume (CTV-to-PTV) margin around the uterine fundus. This work simulates different motion models and margins to estimate the dosimetric consequences. A virtual study used image sets from ten patients. Plans were created with uniform margins of 1 cm (PTV(A)) and 2.4 cm (PTV(C)), and a margin tapering from 2.4 cm at the fundus to 1 cm at the cervix (PTV(B)). Three inter-fraction motion models (MM) were simulated. In MM1, all structures moved with normally distributed rigid body translations. In MM2, CTV motion was progressively magnified as one moved superiorly from the cervix to the fundus. In MM3, both CTV and normal tissue motion were magnified as in MM2, modeling the scenario where normal tissues move into the void left by the mobile uterus. Plans were evaluated using static and percentile DVHs. For a conventional margin (PTV(A)), quasi-realistic uterine motion (MM3) reduces fundus dose by about 5 Gy and increases normal tissue volumes receiving 30-50 Gy by ∼5%. A tapered CTV-to-PTV margin can restore fundus and CTV doses, but will increase normal tissue volumes receiving 30-50 Gy by a further ∼5%.

Entities:  

Mesh:

Year:  2011        PMID: 21490387      PMCID: PMC3167169          DOI: 10.1088/0031-9155/56/10/001

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  12 in total

1.  The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy.

Authors:  M van Herk; P Remeijer; C Rasch; J V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-07-01       Impact factor: 7.038

2.  Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms.

Authors:  D E Heron; K Gerszten; R N Selvaraj; G C King; D Sonnik; H Gallion; J Comerci; R P Edwards; A Wu; R S Andrade; S Kalnicki
Journal:  Gynecol Oncol       Date:  2003-10       Impact factor: 5.482

Review 3.  Errors and margins in radiotherapy.

Authors:  Marcel van Herk
Journal:  Semin Radiat Oncol       Date:  2004-01       Impact factor: 5.934

4.  Motion and deformation of the target volumes during IMRT for cervical cancer: what margins do we need?

Authors:  Linda van de Bunt; Ina M Jürgenliemk-Schulz; Gérard A P de Kort; Judith M Roesink; Robbert J H A Tersteeg; Uulke A van der Heide
Journal:  Radiother Oncol       Date:  2008-01-30       Impact factor: 6.280

5.  An assessment of interfractional uterine and cervical motion: implications for radiotherapy target volume definition in gynaecological cancer.

Authors:  Alexandra Taylor; Melanie E B Powell
Journal:  Radiother Oncol       Date:  2008-06-05       Impact factor: 6.280

6.  Coverage optimized planning: probabilistic treatment planning based on dose coverage histogram criteria.

Authors:  J J Gordon; N Sayah; E Weiss; J V Siebers
Journal:  Med Phys       Date:  2010-02       Impact factor: 4.071

7.  Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation.

Authors:  L Portelance; K S Chao; P W Grigsby; H Bennet; D Low
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-09-01       Impact factor: 7.038

8.  Conventional, conformal, and intensity-modulated radiation therapy treatment planning of external beam radiotherapy for cervical cancer: The impact of tumor regression.

Authors:  Linda van de Bunt; Uulke A van der Heide; Martijn Ketelaars; Gerard A P de Kort; Ina M Jürgenliemk-Schulz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-22       Impact factor: 7.038

9.  Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies.

Authors:  J C Roeske; A Lujan; J Rotmensch; S E Waggoner; D Yamada; A J Mundt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-12-01       Impact factor: 7.038

10.  Inter- and intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy: a cinematic-MRI point-of-interest study.

Authors:  Philip Chan; Robert Dinniwell; Masoom A Haider; Young-Bin Cho; David Jaffray; Gina Lockwood; Wilfred Levin; Lee Manchul; Anthony Fyles; Michael Milosevic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

View more
  5 in total

Review 1.  Problems and solutions in IGRT for cervical cancer.

Authors:  Iván Ríos; Ilse Vásquez; Elsa Cuervo; Óscar Garzón; Johnny Burbano
Journal:  Rep Pract Oncol Radiother       Date:  2018-05-26

Review 2.  The role of intensity modulated radiotherapy in gynecological radiotherapy: Present and future.

Authors:  Ana Fernandez-Ots; Juanita Crook
Journal:  Rep Pract Oncol Radiother       Date:  2013-10-03

3.  Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios.

Authors:  Karen Lim; Beth Erickson; Ina M Jürgenliemk-Schulz; David Gaffney; Carien L Creutzberg; Akila Viswanathan; Lorraine Portelance; Sushil Beriwal; Aaron Wolfson; Walter Bosch; Jennifer De Los Santos; Catheryn Yashar; Anuja Jhingran; Mahesh Varia; Issam El Naqa; Bronwyn King; Anthony Fyles
Journal:  Pract Radiat Oncol       Date:  2015-07-02

4.  RapidArc radiotherapy for whole pelvic lymph node in cervical cancer with 6 and 15 MV: a treatment planning comparison with fixed field IMRT.

Authors:  De-Yin Zhai; Yong Yin; Guan-Zhong Gong; Tong-Hai Liu; Jin-Hu Chen; Chang-Sheng Ma; Jie Lu
Journal:  J Radiat Res       Date:  2012-07-31       Impact factor: 2.724

Review 5.  A practical review of magnetic resonance imaging for the evaluation and management of cervical cancer.

Authors:  Emma C Fields; Elisabeth Weiss
Journal:  Radiat Oncol       Date:  2016-02-02       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.